Literature DB >> 20615225

Quality of reporting of trial abstracts needs to be improved: using the CONSORT for abstracts to assess the four leading Chinese medical journals of traditional Chinese medicine.

Ling Wang1, Yulin Li, Jing Li, Mingming Zhang, Lin Xu, Wenming Yuan, Gang Wang, Sally Hopewell.   

Abstract

BACKGROUND: Due to language limitations, the abstract of journal article may be the only way for people of non-Chinese speaking countries to know about trials in traditional Chinese medicine (TCM). However, little is known about the reporting quality of these trial abstracts. Our study is to assess the reporting quality of abstracts of randomized controlled trials (RCT) published in four leading Chinese medical journals of TCM, and to identify any differences in reporting between the Chinese and English version of the same abstract publication.
METHOD: Two reviewers hand-searched the Chinese Journal of Integrated Traditional and Western Medicine, the Chinese Journal of Integrative Medicine, the China Journal of Chinese Materia Medica and the Chinese Acupuncture & Moxibustion for all abstracts of RCTs published between 2006 and 2007. Two reviewers independently assessed the reporting quality of the Chinese and English version of all eligible abstracts based on a modified version of the CONSORT for reporting randomised trials in journal and conference abstracts (CONSORT for abstracts).
RESULTS: We identified a total of 345 RCTs of TCM with both a Chinese and English abstract. More than half of Chinese abstracts reported details of the trial participants (68%; 234/345), control group intervention (52%; 179/345), the number of participants randomized (73%; 253/345) and benefits when interpreting the trial results (55%; 190/345). Reporting of methodological quality or key features of trial design and trial results were poor; only 2% (7/345) included details of the trial design, 3% (11/345) defined the primary outcome, 5% (17/345) described the methods of random sequence generation, and only 4% (13/345) reported the number of participants analyzed. No abstracts provided details on allocation concealment and trial registration. The percentage agreement in reporting (between the Chinese and English version of the same abstract) ranged from 84% to 100% across individual checklist item.
CONCLUSION: The reporting quality of abstracts of RCTs published in these four TCM journals needs to be improved. Since none of the four journals adopted CONSORT for Abstracts, we hope that the introduction and adoption of CONSORT for Abstracts by TCM journals will lead to an improvement in reporting quality.

Entities:  

Mesh:

Year:  2010        PMID: 20615225      PMCID: PMC2911423          DOI: 10.1186/1745-6215-11-75

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.279


  11 in total

1.  Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.

Authors:  D Moher; A Jones; L Lepage
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

2.  Quality of abstracts in 3 clinical dermatology journals.

Authors:  Alain Dupuy; Kiarash Khosrotehrani; Celeste Lebbé; Michel Rybojad; Patrice Morel
Journal:  Arch Dermatol       Date:  2003-05

3.  Abstracts presented at the American Society of Clinical Oncology conference: how completely are trials reported?

Authors:  Sally Hopewell; Mike Clarke
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

4.  CONSORT for reporting randomised trials in journal and conference abstracts.

Authors:  Sally Hopewell; Mike Clarke; David Moher; Elizabeth Wager; Philippa Middleton; Douglas G Altman; Kenneth F Schulz
Journal:  Lancet       Date:  2008-01-26       Impact factor: 79.321

Review 5.  The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals.

Authors:  Otavio Berwanger; Rodrigo A Ribeiro; Alessandro Finkelsztejn; Marcelo Watanabe; Erica A Suzumura; Bruce B Duncan; P J Devereaux; Deborah Cook
Journal:  J Clin Epidemiol       Date:  2008-11-17       Impact factor: 6.437

6.  Family physicians' use of medical abstracts to guide decision making: style or substance?

Authors:  H C Barry; M H Ebell; A F Shaughnessy; D C Slawson; F Nietzke
Journal:  J Am Board Fam Pract       Date:  2001 Nov-Dec

7.  Chinese authors do need CONSORT: reporting quality assessment for five leading Chinese medical journals.

Authors:  Lin Xu; Jing Li; Mingming Zhang; Changlin Ai; Ling Wang
Journal:  Contemp Clin Trials       Date:  2008-05-18       Impact factor: 2.226

8.  Quality of abstracts of original research articles in CMAJ in 1989.

Authors:  L Narine; D S Yee; T R Einarson; A L Ilersich
Journal:  CMAJ       Date:  1991-02-15       Impact factor: 8.262

9.  Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association.

Authors:  A Taddio; T Pain; F F Fassos; H Boon; A L Ilersich; T R Einarson
Journal:  CMAJ       Date:  1994-05-15       Impact factor: 8.262

10.  CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.

Authors:  Sally Hopewell; Mike Clarke; David Moher; Elizabeth Wager; Philippa Middleton; Douglas G Altman; Kenneth F Schulz
Journal:  PLoS Med       Date:  2008-01-22       Impact factor: 11.069

View more
  20 in total

Review 1.  Barriers to translating EU and US CVD guidelines into practice in China.

Authors:  Dong Zhao; Dayi Hu
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

2.  Effect of regulation reform on clinical trials for registering novel therapeutic agents in Taiwan: a chronological analysis.

Authors:  I-Chen Sun; Horng-Shing Shy; Tzu-Ya Liao
Journal:  Invest New Drugs       Date:  2016-01-16       Impact factor: 3.850

Review 3.  Therapeutic potential of ginseng in the management of cardiovascular disorders.

Authors:  Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

4.  Reporting of health promotion research: addressing the quality gaps in iran.

Authors:  Abdolreza Shaghaghi; Hossein Matlabi
Journal:  Health Promot Perspect       Date:  2012-07-01

5.  Pharmacy journal abstracts published in PubMed that abide by the CONsolidated Standards Of Reporting Trials (CONSORT) guidelines.

Authors:  Daniel A Blair; Peter J Hughes; Thomas W Woolley
Journal:  J Med Libr Assoc       Date:  2014-04

6.  Assessment of adherence to the CONSORT statement for quality of reports on randomized controlled trial abstracts from four high-impact general medical journals.

Authors:  Saurav Ghimire; Eunjung Kyung; Wonku Kang; Eunyoung Kim
Journal:  Trials       Date:  2012-06-07       Impact factor: 2.279

7.  Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals.

Authors:  Senthil P Kumar
Journal:  Indian J Palliat Care       Date:  2011-01

Review 8.  Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews.

Authors:  Jia He; Liang Du; Guanjian Liu; Jin Fu; Xiangyu He; Jiayun Yu; Lili Shang
Journal:  Trials       Date:  2011-05-13       Impact factor: 2.279

9.  Refining a taxonomy for guideline implementation: results of an exercise in abstract classification.

Authors:  Danielle Mazza; Phillip Bairstow; Heather Buchan; Samantha Paubrey Chakraborty; Oliver Van Hecke; Cathy Grech; Ilkka Kunnamo
Journal:  Implement Sci       Date:  2013-03-15       Impact factor: 7.327

Review 10.  Reporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignancies.

Authors:  Shanthi Sivendran; Kristina Newport; Michael Horst; Adam Albert; Matthew D Galsky
Journal:  Trials       Date:  2015-08-08       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.